Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
about
Imaging characteristics, tissue distribution, and spread of a novel oncolytic vaccinia virus carrying the human sodium iodide symporterApplications of 211At and 223Ra in targeted alpha-particle radiotherapyMolecular imaging of oncolytic viral therapyOncolytic viral therapy for pancreatic cancer: current research and future directionsTrial Watch:: Oncolytic viruses for cancer therapyDesign and development of a robotized system coupled to µCT imaging for intratumoral drug evaluation in a HCC mouse modelThe Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) ProteinMeasles to the Rescue: A Review of Oncolytic Measles VirusThe use of the NIS reporter gene for optimizing oncolytic virotherapyMicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropismViral oncolysis - can insights from measles be transferred to canine distemper virus?Cancer screening by systemic administration of a gene delivery vector encoding tumor-selective secretable biomarker expressionSodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Pinhole micro-SPECT/CT for noninvasive monitoring and quantitation of oncolytic virus dispersion and percent infection in solid tumors.Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene deliveryImage-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cellsOncolytic measles virus encoding thyroidal sodium iodide symporter for squamous cell cancer of the head and neck radiovirotherapy.Curative one-shot systemic virotherapy in murine myeloma.HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapyOncolytic measles virus strains as novel anticancer agents.A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity.Monitoring the initial delivery of an oncolytic measles virus encoding the human sodium iodide symporter to solid tumors using contrast-enhanced computed tomographyUse of attenuated paramyxoviruses for cancer therapy.The use of molecular imaging of gene expression by radiotracers in gene therapy.Pancreatic cancer gene therapy: from molecular targets to delivery systems.Antitumor Virotherapy by Attenuated Measles Virus (MV).Potential and clinical translation of oncolytic measles viruses.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Oncolytic viral therapy for pancreatic cancer.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.Measles virus causes immunogenic cell death in human melanoma.EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.[Measles virus: a future therapeutic agent in oncology?].Estimation of Oncolytic Virus Populations within Tumors
P2860
Q21134124-34A4B74E-C168-49B9-875E-890BE8249048Q24610016-FC3595EB-1365-4876-BC70-090AE258FF0FQ26999406-907404CE-FBF7-4E5B-80A1-22CAEBD8880BQ27011439-8C9B227D-B962-4C07-8F5C-CA11566CFD54Q27021951-1F60D8EA-36D2-4A94-8638-50BF226375A3Q27312299-D11111A1-FF6B-4CBB-848A-8F862789F2A2Q28069519-C81B52EB-DE8C-4D42-95B4-29C3382E0092Q28072097-D5165B0C-4B7A-4862-8107-CB9FBDE597F0Q28083534-96A61D34-8086-4AF1-A97D-54AD2347F90BQ30502129-A3F9EF58-4C71-4217-A6B3-77AA5F21FF16Q33820717-51128317-765A-4EE9-A247-23075BED312CQ33903856-CDCC4C3F-1C6C-458E-B3CB-3B0450A085D6Q34303955-9EFE4187-D55C-493C-AB11-C7C546BBAA62Q34470472-A86A6F30-12A2-41A1-8044-CEDAA4B2F6E2Q34698684-5A286E9E-1D92-49C8-A889-1EFA9C87C78BQ35415103-FB133E1C-6271-4F45-B847-1BBC37CCB704Q35575677-F88AF4CB-3309-4A5C-9680-881D34BBC707Q35612571-24EEB756-FE8F-470E-9D3B-A82FCDD4984AQ35728290-7B031B03-D849-446C-BF6B-B1C2F15285D2Q35823934-E6543D59-2DB2-4166-A90A-B5B5F0EE56F2Q36139716-F8987570-87D0-4A78-AB68-6054A20C2919Q37104963-AA1A5DC9-893A-4308-8ED1-725A49185262Q37261017-137A503E-5EF9-445D-AA82-1982400EC8E9Q37388411-00EBAD3C-6BA6-43B4-AFE1-AD03419B677DQ37594715-C3D84001-3CBD-4D56-9C47-658D756BBFFFQ37810599-52C0541E-FFBD-4B70-94F3-C9BDF2BA5C11Q37884052-6F4C3785-D725-4FB1-A9BF-B7213830B789Q38161331-86A0234F-CD19-4667-ACFC-7348740E224AQ38212137-EAF78720-20A4-4065-8424-055BB9A76D27Q38764947-B5C915CB-5B43-4B2F-988D-69883E1005D4Q38772380-A00F3D6D-FCE4-48F6-B687-655D0A651AC5Q39240683-D17AD17E-C05B-419E-A10B-92818D6A97DEQ39315516-891EBC3A-0273-4410-9BD8-5376AF112009Q39428453-7E80A3A1-1340-42B6-A595-21B9CDC07C61Q45326571-99684E88-C174-4B33-86D2-19ECB5ECB137Q45866837-EF295922-17ED-481D-91C1-087B726BE50EQ53171426-504992CB-59EC-4590-B339-6D205B1593EDQ57462027-856F2321-668B-4781-806B-1EF285F3479C
P2860
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@ast
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@en
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@nl
type
label
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@ast
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@en
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@nl
prefLabel
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@ast
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@en
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@nl
P2093
P2860
P3181
P356
P1476
Sodium iodide symporter (NIS)-mediated radiovirotherapy for pancreatic cancer
@en
P2093
Alan R Penheiter
Claire E Bender
Kelly L Classic
Stephanie K Carlson
Troy R Wegman
P2860
P3181
P356
10.2214/AJR.09.3672
P407
P577
2010-08-01T00:00:00Z